STING agonist combined with Vps34 inhibitor results in markedly reduced tumour size STING agonist combined with Vps34 inhibitor results in markedly reduced tumour size April 2024 Science Read more
2020 April ESMO 2019 Half of the patients with metastatic melanoma treated with nivolumab-ipilimumab are still aliv... Read more
2020 April ASCO 2019 Ramucirumab plus erlotinib improves progression-free survival in EGFR-positive lung cancer Read more
2020 April ASCO 2019 NEOSTAR: pre-surgical checkpoint inhibition effective in early stage lung cancer Read more
2020 April ASCO 2019 FOLFOXIRI + bevacizumab shows progression-free survival benefit in mCRC patients with ≥3 bas... Read more
(sponsored) 2020 February Pharma News Mosunetuzumab effective in heavily pretreated non-Hodgkin lymphoma Read more
2020 February ASCO 2019 Pembrolizumab increases historic survival rate for certain people with advanced NSC lung cance... Read more